CD33/CD3-bispecific T-cell engaging (BiTE (R)) antibody construct targets monocytic AML myeloid-derived suppressor cells
- Resource Type
- Journal
- Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER ; NOV 5 2018, 6 p116 6p.- Subject
- Language
- English
- ISSN
- 20511426